IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS)
This study has been terminated.
(Lack of funding)
Sponsor:
Nova Scotia Health Authority
Collaborator:
Sanofi
Information provided by:
Nova Scotia Health Authority
ClinicalTrials.gov Identifier:
NCT00688948
First received: May 30, 2008
Last updated: June 23, 2011
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | November 2009 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |